Home › Teva Pharmaceutical Industries Given New $46.00 Price Target at BMO Capital Markets
 

Keywords :   


Teva Pharmaceutical Industries Given New $46.00 Price Target at BMO Capital Markets

2014-03-02 18:23:35| Biotech - Topix.net

BMO Capital Markets' price objective would indicate a potential downside of 7.80% from the company's current price.

Tags: price capital target industries

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10Hurricane Leslie Graphics
06.10Hurricane Leslie Forecast Discussion Number 16
06.10Hurricane Leslie Wind Speed Probabilities Number 16
06.10Hurricane Leslie Forecast Advisory Number 16
06.10Hurricane Leslie Public Advisory Number 16
06.10Summary for Hurricane Leslie (AT3/AL132024)
06.10Hurricane Kirk Graphics
06.10Tropical Storm Milton Graphics
More »